Related Articles
According to licensed radiation therapist (RTT) and Elekta Unity product manager Liz Knowles, radiation therapy technology will fail if vendors don’t do four key things: involve the user upfront in development, take the time to develop and iterate on solutions carefully, push for consensus-driven standardization and design the technology for the mainstream user – not…
U.S. News & World Report recently evaluated 899 hospitals to determine which ones offered the very best cancer care. The common denominator for the highest-ranking hospitals is that they all rely on Elekta’s cutting-edge cancer treatment equipment. The solutions range from our flagship Elekta Unity MR-Linac, that enables a scan-plan-treat approach for accurate dose delivery…
In the 2020 TROG SBRT Liver Plan Study sponsored by ProKnow, Elekta China’s Dr. Jiaqi Dai achieved a score of 148.66 out of 150, earning him Special Recognition for Top VMAT Score among 137 submissions for the liver SBRT plan from participants from around the world. The results were announced on March 17. The challenge…
According to the Health Department of Abu Dhabi, approximately 4,500 new cases of cancer are reported every year in the United Arab Emirates (UAE). Nevertheless, the country aims to reduce fatalities by 18 percent by 2021. Elekta’s strategy is to be the partner of choice for the Middle East and North Africa (MENA) region –…
Popular applications from PalabraApps, LLC will become standard solutions of Elekta’s MOSAIQ® Oncology Information System by virtue of Elekta’s acquisition of the company. The agreement, announced on February 20, comes nearly three years after Elekta began collaborating with PalabraApps on innovative workflow productivity and mobility solutions for integration with MOSAIQ. PalabraApps’ voice automation improves a…
Elekta Beijing Medical Systems (EBMS) Co., Ltd. recently produced its 100th high-energy linear accelerator (linac), an Elekta Synergy® system. A linac is a device used to treat tumors in people with cancer by delivering radiation therapy in the form of high-energy x-rays or electrons. Like Elekta’s Crawley, UK facility, EBMS is now a major manufacturer of…
As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible.
The products and product clinical indications for use described within FOCUS may not have clearance or registration in certain countries. Please consult Elekta in your country for questions concerning a product or clinical use subject. This site may contain information provided by third party sources to Elekta that does not necessarily represent the views of Elekta. Individuals interviewed provided information based on their personal experience and were not compensated for their participation. Accordingly, third party information contained in this site is provided "as is" with no guarantees of completeness, accuracy, usefulness, or timeliness.
© 2021 Elekta | FOCUS Magazine. | Privacy Policy | Cookies
